))
Episode 25: Weighing the Risks and Benefits of GLP-1 Medications
Manage episode 451155256 series 3593068
Indhold leveret af Loni and Christine. Alt podcastindhold inklusive episoder, grafik og podcastbeskrivelser uploades og leveres direkte af Loni and Christine eller deres podcastplatformspartner. Hvis du mener, at nogen bruger dit ophavsretligt beskyttede værk uden din tilladelse, kan du følge processen beskrevet her https://da.player.fm/legal.
In this episode we dive into the world of GLP-1 receptor agonists - the class of medications (e.g., Ozempic and Wegovy) making headlines for their role in weight management and diabetes care. We explore the science behind GLP-1 medications, their impact on metabolic health, and their growing popularity beyond diabetes treatment. However, it's not all smooth sailing; side effects, accessibility, and long-term outcomes are part of the conversation, too. Whether you're a healthcare professional, a curious patient, or interested in the latest medical advancements, this balanced discussion will help you better understand this groundbreaking class of medications.
29 episoder
Del
